Skip to main content
Equibles
ENTX logo

ENTX · Entera Bio Ltd. · Analyst Estimates

Track ENTX — free

Use ENTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.79 -0.05 (-1.76%) At close · Sep 10
Rebalance outlook locked
Going-concern doubt — cleared Aug 7, 2026

The latest filing states the doubt was alleviated.

“Following the closing of the private placement and receipt of the related net proceeds, management concluded that substantial doubt about the Company’s ability to continue as a going concern no longer exists.”
View the 10-Q filed Aug 7, 2026
Market Cap
$482.20M
Shares
173.14M

Analyst Estimates

Compare analyst forecasts for Entera Bio Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1638097 CUSIP M40527109 13F (30d) 21 filings 21 filers Visit website Investor relations